Cargando…

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients

Detalles Bibliográficos
Autores principales: Morse, Michael A, Hobeika, Amy, Gwin, William, Osada, Takuya, Gelles, Jonathan, Rushing, Christel, Niedzwiecki, Donna, Lyerly, H Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652494/
http://dx.doi.org/10.1186/2051-1426-3-S2-P444
_version_ 1782401766101352448
author Morse, Michael A
Hobeika, Amy
Gwin, William
Osada, Takuya
Gelles, Jonathan
Rushing, Christel
Niedzwiecki, Donna
Lyerly, H Kim
author_facet Morse, Michael A
Hobeika, Amy
Gwin, William
Osada, Takuya
Gelles, Jonathan
Rushing, Christel
Niedzwiecki, Donna
Lyerly, H Kim
author_sort Morse, Michael A
collection PubMed
description
format Online
Article
Text
id pubmed-4652494
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46524942015-11-25 Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients Morse, Michael A Hobeika, Amy Gwin, William Osada, Takuya Gelles, Jonathan Rushing, Christel Niedzwiecki, Donna Lyerly, H Kim J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652494/ http://dx.doi.org/10.1186/2051-1426-3-S2-P444 Text en Copyright © 2015 Morse et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Morse, Michael A
Hobeika, Amy
Gwin, William
Osada, Takuya
Gelles, Jonathan
Rushing, Christel
Niedzwiecki, Donna
Lyerly, H Kim
Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
title Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
title_full Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
title_fullStr Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
title_full_unstemmed Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
title_short Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
title_sort phase i study of alphaviral vector (avx701) in colorectal cancer patients: comparison of immune responses in stage iii and stage iv patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652494/
http://dx.doi.org/10.1186/2051-1426-3-S2-P444
work_keys_str_mv AT morsemichaela phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT hobeikaamy phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT gwinwilliam phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT osadatakuya phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT gellesjonathan phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT rushingchristel phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT niedzwieckidonna phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients
AT lyerlyhkim phaseistudyofalphaviralvectoravx701incolorectalcancerpatientscomparisonofimmuneresponsesinstageiiiandstageivpatients